NEUSERINE Trademark

Trademark Overview

On Tuesday, July 10, 2018, a trademark application was filed for NEUSERINE with the United States Patent and Trademark Office. The USPTO has given the NEUSERINE trademark a serial number of 88031647. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by SyneuRx International (Taiwan) Corp. The NEUSERINE trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosm...
neuserine

General Information

Serial Number88031647
Word MarkNEUSERINE
Filing DateTuesday, July 10, 2018
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6811004
Registration DateTuesday, August 9, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosmetics; amino acids for medical purposes, excluding amino acids for use in skin care products or cosmetics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSyneuRx International (Taiwan) Corp
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Taipei City 221
TW
Party NameSyneuRx International (Taiwan) Corp
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Taipei City 221
TW
Party NameSyneuRx International (Taiwan) Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Taipei City 221
TW

Trademark Events

Event DateEvent Description
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Friday, July 1, 2022TTAB RELEASE CASE TO TRADEMARKS
Friday, July 1, 2022OPPOSITION TERMINATED NO. 999999
Friday, July 1, 2022OPPOSITION DISMISSED NO. 999999
Wednesday, February 10, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, February 10, 2021OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2020CASE RETURNED TO EXAMINATION
Wednesday, December 9, 2020NOTICE OF ALLOWANCE CANCELLED
Wednesday, December 2, 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, December 2, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, December 1, 2020ASSIGNED TO PETITION STAFF
Saturday, November 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 12, 2020SOU EXTENSION 3 GRANTED
Thursday, November 12, 2020SOU EXTENSION 3 FILED
Thursday, November 12, 2020TEAS EXTENSION RECEIVED
Thursday, October 1, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Friday, July 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 24, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 21, 2020SOU EXTENSION 2 GRANTED
Tuesday, April 21, 2020SOU EXTENSION 2 FILED
Tuesday, April 21, 2020TEAS EXTENSION RECEIVED
Thursday, October 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2019SOU EXTENSION 1 GRANTED
Tuesday, October 15, 2019SOU EXTENSION 1 FILED
Tuesday, October 15, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 29, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, March 26, 2019ASSIGNED TO PETITION STAFF
Sunday, March 24, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 5, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, December 12, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2018ASSIGNED TO EXAMINER
Saturday, July 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuserine medical purposes care skin excluding disorder products amino disorders preparations